FFM, fat-free mass SF, skinfold TBW, total body water FQ, food quotient RQ, respiratory quotient 2H 2 0 , deuterium oxide rC0 2 , mean daily CO 2 production Abbreviations CF, cystic fibrosis REE, resting energy expenditure TEE, total energy expenditure FVC, forced vital capacity FEV.. forced expiratory volume in 1 s FEF 25-75' forced expiratory flow between 0.25 and 0.75 s 2H, deuterium 180,oxygen-18 BW, body weight ABSTRACT. Increased energy expenditure, poor dietary intake, and fat malabsorption in patients with cystic fibrosis (CF) frequently lead to growth failure and malnutrition, which are associated with pulmonary failure and decreased survival. The study purpose was to understand better the energy expenditure and requirements in the mild pulmonary disease state in children. Resting and total energy expenditure were measured in 6-to 9-yr-old, pancreaticinsufficient children with CF (n =25) and control children (n = 25) of similar age, gender, and weight. The effect of the most common genotype, homozygousaF508, on energy expenditure was also investigated. Dietary intake, degree of fat malabsorption, body composition, physical activity, and clinical status were determined. The CF group had a 9% increase in resting energy expenditure, which was not related to genotype or severity of lung disease. Both CF genotype subgroups (aF508 homozygous and all others) had a similar, modest resting energy expenditure increase. Total energy expenditure was increased by 12% in the entire CF group and by 23% in the aF508 homozygous CF subgroup compared with controls. The total energy expenditure increase in aF508 homozygous children may be related to increased voluntary physical activity, reflecting no activity reduction associated with lung disease, or to an unidentified genotype-related mechanism. The clinical implication is that a detailed physical activity assessment should be evaluated along with resting energy expenditure, either measured or estimated by equations, when daily energy needs are being determined for children with CF. (Pediatr Res 35: 451-460, 1994) CF, a common lethal genetic disorder with an autosomal recessive pattern of inheritance, is caused by mutations in the CF transmembrane conductance regulator gene (1-3). Generalized exocrine gland dysfunction results in abnormalities in several organ systems (4). In addition to the excessive losses of sodium chloride in sweat, abnormal mucus in the lungs contributes to the development of chronic obstruction, infection, and inflammation. Exocrine pancreatic insufficiency occurs in more than 85% of patients with CF, and, despite enzyme replacement therapy, malabsorption of fat and micronutrients may occur. According to a 1990 CF Foundation report, about 50% of patients cared for in the 114 organized CF centers had growth failure, with weight and/or height less than the 10th percentile for age and gender (5). CF-related growth failure is often attributed to chronic lung disease, although this causal relationship is not established.
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Malnutrition may be caused by inadequate caloric intake, increased energy requirements, or both. The cause of the inadequate caloric intake is multifactorial, partly resulting from anorexia associated with lung infection and gastrointestinal discomfort associated with pancreatic insufficiency. Ingestion of multiple medications further interferes with appetite and food intake. Nutrient absorption, particularly fat, usual1y is decreased despite pancreatic enzyme supplementation. Energy expenditure may be increased as a result of chronic lung infection, fever, bronchodilator medications, a theorized increased work of breathing, and a possible basic molecular defect. The resulting negative energy balance depletes the body of its energy stores and impedes normal growth. Pencharz et al. (6) proposed that a vicious cycle is created in which the malnourished state places the child at risk for impoverished health because of lowered immune function, in-452 TOMEZSKO ET AL.
reported by Shepherd et al. (9) to be increased in clinically well infants and toddlers with CF. In contrast, Spicher et al. (10) , using a cumulative heart rate monitor method, found TEE to be equivalent between CF and healthy subjects despite increased REE in the CF group.
Contrasting findings exist regarding the pattern of energy expenditure among patients with the various genotypes of CF. Fried et al. (II) found that in normally nourished men and boys with CF and good pulmonary function no association existed between REE and the~F508 homozygous genotype. Conversely, O'Rawe et al. (12) found that 7-to 15-yr-old subjects homozygous for~F508 had higher REE compared with~F508 heterozygous subjects or subjects with other mutations.
This study was designed to evaluate energy expenditure in a homogeneous prepubertal CF group who had pancreatic insufficiency, were well nourished with normal growth and body composition, and had mild pulmonary disease. This study avoids confounding variables such as poor lung function, malnutrition, and variable stages of pubertal development. The study hypotheses were as follows: J) REE and TEE are higher in children with CF as compared with similar control children and 2) energy expenditure is related to CF genotype.
MATERIALS AND METHODS
Patients. Twenty-five prepubertal patients with CF were recruited from the CF center at The Children's Hospital of Philadelphia. Children were diagnosed with CF on the basis of clin ical symptoms and duplicate quantitative pilocarpine iontophoresis sweat tests with sodium and chloride values greater than 60 mfiq-1-1. All children were determined to be pancreatic insufficient on the basis of fecal fat analysis of a 72-h stool collection with 90% or less fat absorption, a stool trypsin value of less than 80 Ilm· g-I , or both. Selection criteria for patients with CF were defined as follows: 1) 5 to 10 years of age, 2) no hospitalization 6 wk before the study, 3) no acute pulmonary exacerbation or other acute illness at the time of data collection, and 4) no other disease or prescribed medication known to affect growth . Study data were collected at the time of the routine annual comprehensive examination.
Twenty-five healthy children from hospital and community sources were recruited as control subjects. The enrollment of these children began after approximately one half of the CF group had been evaluated. The group of children with CF provided selection criteria for controls to ensure comparable age, gender, and weight. General selection criteria for control subjects were as follows: 1) 5 to 10 years of age, 2) a weight range of 16 to 34 kg, 3) no known chronic or acute illness at the time of data collection, and 4) no other disease or prescribed medication known to affect growth. Individual matching of CF and control subjects was not carried out.
The study was conducted in the Nutrition and Growth Laboratory and the General Clinical Research Center of The Children's Hospital of Philadelphia during an 18-h overnight admission. Both parents and children gave informed written consent, and the protocol was approved by the Committee for the Protection of Human Subjects.
Growth and anthropometry. Weight, height, and SF thicknesses (triceps, biceps, subscapular, and suprailiac) were measured by one observer (J.T.) with standard methods as previously described (13, 14) . Weight and height values were compared with National Center for Health Statistics reference standards (15) , and percentiles and z scores were determined (Centers for Disease Control Anthropometric Software Program, Version 3.1, 1988, Division of Nutrition, Centers for Disease Control, Atlanta, GA). Ideal BW was determined as the weight that corresponded to the weight for age percentile equal to the actual height for age percentile on the National Center for Health Statistics growth chart (16) . Percentage body fat was calculated using the triceps and subscapular SF in the prepubertal prediction equations of Slaughter et al. (17) , which are adjusted for body density, body water, and bone density. FFM was determined using TBW values from 2H 2 0 dilution and assuming a 75.3% hydration factor of FFM in prepubertal children (18, 19) .
Clinical status assessment. Clinical assessment of the patients with CF was based on consensus chest roentgenogram scores determined by two pediatric pulmonary physicians using the scoring system as described by Brasfield et al. (20) . Clinical symptoms were rated by scores as described by Shwachman and Kulczycki (21) . Pulmonary disease was evaluated at the time of the study in all patients with CF with standard pulmonary funct ion methods for spirometry and plethysmography and compared with appropriate reference values (22, 23) . These entities included FVC, FEV 10 FEF 2S _7S, and residual volume.
Three-day, weighed food records were collected at home as previously described (13) . Food intake data were analyzed for 20 nutrients (Food Processor II Program-ESHA Research, Salem, OR). The home-based 72·h stool collection was begun on the 2nd d of the 3-d food record. Fecal fat was analyzed by the van de Kamer method (24) (Hahnemann University Hospital, Philadelphia, PAl or by a gravimetric method (Mayo Medical Laboratories, Rochester, MN) . The coefficient of fat absorption was determined from fecal fat and dietary fat intake (25) .
REE. REE was measured by open-circuit indirect calorimetry. In preparation, each child was admitted the preceding afternoon and received an evening meal that was standardized for calories, carbohydrate, protein, and fat. Each child fasted from food and medication for 12-14 h before REE testing. In the early morning the child was awakened, an axillary temperature was recorded, and physical activity was restricted.
A computerized metabolic cart (Gould 2900 or SensorMedic 2900 Z, SensorMedics, Yorba Linda, CAl was used to measure REE for 60 min in a quiet, thermoneutral room. A large, clear ventilated hood for sampling gases was placed over the head of the subject while he or she was resting in a supine position. The modified equation as described by Weir (26) was used to calculate energy equivalency from the oxygen consumption and carbon dioxide production. The first 10 min were devoted to environmental adjustment by the child and were eliminated from calculations. REE data were compared with predicted values from World Health Organization basal metabolic rate equations (27) .
TEE and TBW. TEE was measured by the doubly labeled water method. The 2H 20 dose was 0.14 g 2H 20· kg estimated TBW-I (28) and was 99.8 atom percent deuterium (Aldrich, Milwaukee, WI). The dose of 18 0 in water was 0.3 g H 2 180 .kg estimated TBW-I (28) and ranged from 14 to 15%
On the day of admission, fasting began at 1830 h, and a baseline urine sample was collected. At 2000 h, the isotopes were administered orally . Overn ight urine and the first urine void of the morning ( I) were collected and pooled to adjust for isotope losses. The second urine void of d I was collected to determine TBW e H 2 0 ) and to begin the TEE metabolic period. At home, the first urine voids of d 4, 7, and 10 were collected . The subjects observed their typical daily routines in their usual environment. Urinary 2H and 18 0 isotopic abundances were measured by isotope ratio mass spectroscopy (Nuclide 6-60, State College, PA; Global Geochemistry Corporation, Canoga Park , CAl . Urinary 2H samples were analyzed in duplicate, with reproducibility of ±5 parts per mille for isotopically enriched samples and ±3 parts per mille for the unenriched baseline samples. One out of 10 18 0 samples were analyzed in duplicate, and reproducibility was ±O.I parts per mille.
Standard equations for calculation of TEE (18) were used, with adjustment for overnight loss after dosing: rC02 = (N/ 2.078) (1.01 k, -1.04 k H ) -0.0246 ror, where rC0 2 is mean daily CO 2 production, N is TBW, k, and k H are larger than the body water pool, 4% and 1% respectively (18) , and that fractionated water loss is about 23% of total water turnover (29) . The elimination rates for 18 0 (ko) and 2H (k«)
were determined with the two-point method. The 9-d metabolic period was defined as the difference between d I and d 10. The d 7 rC0 2 was used as a consistency check of d 10 rC02• If rC02 differed more than 10% between the 2 d, data for that subject were excluded because of unacceptable variability. RQ was estimated from the FQ (30), calculated from 3-d diet records during the metabolic period. In the patients with CF, the FQ was adjusted for the coefficient of fat absorption. TEE data were compared with World Health Organization recommended energy requirements for children (27) . Factors affecting the TEE metabolic period were recorded, i.e yearly season of metabolic period and prescribed use ofbronchodilators that increase energy expenditure-heart rate. Documentation of actual bronchodilator compliance was not obtained.
Genotype analysis. Genomic DNA was isolated from blood samples (Applied Biosystems, Model 340A Nucleic Acid Extractor, Foster City, CA). The presence of the .6.F508 mutation was determined by allele-specific oligonucleotide hybridization as described in Kerem et al. (3) . Patients with CF were classified as .6.F508 homozygous, .6.F508 heterozygous, or having other mutations. Control subjects were not evaluated.
Estimates of physical activity. Parents estimated their child's physical activity each day during the metabolic period. A questionnaire adapted from Murphy et al. (31) provided a score for daily physical activity: sedentary = I, slightly active = 2, moderately active = 3, and active = 4. Parents chose the category that best described the child's physical activity for each day, and the mode score for the 9-d metabolic period was used to classify the overall activity. The TEE/REE ratio, representing the energy used for physical activity, thermic effect of food, and growth, was also calculated. KEY:
• CF, 0 N, Sample Size (N) I into two subgroups: homozygous AF508 and all other genotypes. Univariate comparisons for ordinal scaled variables were accomplished with the Wilcoxon rank sum statistic, and categorical variables were determined by corrected x 2 and Fisher's exact tests. All data analysis was performed with SAS (SAS Institute , Cary, NC), with a conservative two-tailed testing approach.
The primary analysis for energy expenditure differences of groups and subgroups was based on linear model adjustment using covariates known or suspected to influence energy expenditure . This analysis of covariance method accommodated adjustment for weight, gender, body composition measures of FFM , and genotype. It also allowed the interaction of these covariates to be evaluated and the validity of the model(s) to be assessed. A small bias may appear in these estimates with FFM adjustment because of the inherent variability associated with its estimation. Outliers in these models were identified by evaluating studentized residuals for each model. Sensitivity analyses were performed by deleting outlier observations, applying logarithm transforms, and estimating missing values by the method of Bartlett (32) . Pulmonary function differences between the two subgroups of chilo dren with CF were evaluated with the linear model with adjustment for age, gender, and weight.
RESULTS
Growth and clinical characteristics. Growth and body composition characteristics for all subjects are presented in Table I . Age, weight, and height were similar for the CF and control groups, which reflects the procedure used for selecting controls. However, mean height for age percentile was lower for the CF group. Nutritional status, as indicated by percentage ideal BW, was similar for both groups. Most body composition measures were comparable, with the exceptions of triceps z score and percentage body fat determined by TBW, both of which were lower for the CF group. Mean ± SD (range) of pulmonary function, indicated by FEY t percentage predicted, was 89 ± 16% (61-1 17%), and the chest roentgenogram score was 21 ± 2 (16-24), out of a maximum score of 25. These measures indicated mild pulmonary disease for the children with CF. The CF clinical severity score was 89 ± 5 (78-97), which reflects excellent clinical status.
REE. The REE results of four subjects (two with CF and two control) were omitted because of equipment malfunction. REE values (Table 2 ) demonstrated higher means in children with CF, e.g. an 8.5% difference between mean values for kcal-kg -d •~F508/~F508 homozygousgenotype;~F508/0 heterozygousand unknown mutation; % unknown mutation . t CI, confidence interval. Controlling for gender and FFM-SF provided an adjusted group difference of 60.6 kcal-d"" (p = 0.003). Gender was not an important factor for adjustment with FFM-TBW (p =0.14).
The influence of two control subject outliers (Fig. IA) was investigated and did not alter results. In fact , analysis excluding the two outliers resulted in more significant p values for differences between groups, e.g. p = 0.02 with FFM-TBW (Fig. IC) .
Genotype classifications (Table 3 ) had 14 (56%) patients who were homozygous for the IlF508 mutation, 7 (28 %) heterozygous (IlF508/unknown), and 4 (16%) unknown mutations. These latter II patients were grouped together as the mixed heterozygous subgroup and compared with the 14 homozygous patients. Adjusting for weight and FFM separately yielded similar REE results for the two CF subgroups ( Fig. 2A-C) . The REE for both CF subgroups was significantly higher than the control group when the model was adjusted for either weight or FFM-SF. When FFM-TBW was used to adjust the model, the homozygous subgroup was not different from controls (p = 0.18). Estimated mean REE differences between the two CF subgroups were 5. TEE. The TEE results of eight subjects (six with CF and two control) were excluded because of unacceptably high variability in reo2• The CF group (Table 2) had 12% higher TEE expressed as kcal -kg body weight'l -d'" compared with the control group, with 95% confidence intervals of76 to 92 and 71 to 79, respectively. Mean differences between the TEE of CF and control groups were 9-12% less in the control group when TEE were expressed in other units.
Analysis of TEE as measured by kcal-d" yielded a significant difference of 216 kcal-d-I (p =0.04) between the CF and control groups when adjusted for weight (Fig. 3A) . TEE analysis, adjusted for weight and gender (Fig. 3D) showed that boys had higher TEE, 234 kcal-d', in both CF and control groups. When FFM-SF or FFM-TBW were used for adjustment ( Fig. 3C and D) , in both groups. Small differences were found between the two genotype subgroups and the control group in caloric intake ( Table 3 ). The mean coefficient of fat absorption from the stool analysis for 23 of the patients with CF was 87%, and the median value was 90%. FQ, calculated from TEE metabolic period diet records, was used to determine RQ for the calculation of TEE. RQ for patients with CF was adjusted for loss of stool fat with the coefficient of fat absorption. The mean RQ for the CF group was 0.88 before and after stool fat adjustment, and the unadjusted FQ, also 0.88, was used as the RQ for the control group.
The effect of lung disease on REE and TEE, as measured by FEV 1 and FVC% predicted, resulted in no significant associations. When genotype subgroup data were compared, including age, gender, and weight (either singly or combined) in the linear model, similar results were found. Patients with CF were examined for the effect of genotype (.:lF508 homozygous subgroup versus mixed heterozygotes) on pulmonary function. Nonsignificant differences (mean ± SD) were observed: FVC, 105 ± 12% versus 99 ± 12% predicted; FEV .. 93 ± 14% versus 85 ± 19% predicted; FEV1/FVC, 90 ± 10% versus 85 ± 16% predicted; FEF 2S _7S, 75 ± 24% versus 72 ± 38% predicted; and residual volume, 144 ± 54% versus 178 ± 48% predicted. The .:lF508 homozygous subgroup tended to have better scores for these pulmonary measures.
TEE divided by REE is an indicator of physical activity and thermic effect of food during the 9-d metabolic period. Thermic effect of food was not measured and was assumed to be similar in all groups and subgroups. The TEE/REE ratios (Table 2) were not statistically different between the entire CF and control groups, adjusting for weight or FFM. However, a difference in the ratio was noted between the .:lF508 homozygous and the mixed heterozygous subgroups ( Table 3 ). The control group ratio, which was located between those of the two CF subgroups, was different from both. Physical activity scores from parental observations for the two genotype CF subgroups and the control group were compared with rank test procedures, and no differences were observed.
DISCUSSION
There were several salient findings in this study of adequately nourished, prepubertal, pancreatic-insufficient children with mild lung manifestations of CF. First, REE was increased 6-9% above controls and appeared independent of genotype subgroup CF, GENOTYPE, AND ENERGY EXPENDITURE 457 B) 20 30 40 Weight ( ,., (~F508 homozygous compared with all others) or of mild pulmonary dysfunction. Second, TEE was about 15-18 % greater in children with CF compared with controls. The statistical significance of this increase was documented by sensitivity analysis methods, including estimation of missing TEE values. Third, the increase in CF TEE was attributed principally to the~F508 homozygous subgroup and was not explained by pulmonary function, the season during which TEE was measured, or use of bronchodilator medications. Vaisman et al. (33) found that REE was increased by use of salbutamol in patients with CF. Physical activity, as reflected by the TEE/REE ratio, was increased in thẽ F508 homozygous subgroup. It appears that in this CF subgroup with mild lung disease no compensation by decreased physical activity occurred, as described by Spicher et al. (10) .
However, the subjective activity score from parental observations showed no difference in physical activity between the CF and control groups or between the two CF subgroups and controls. It is generally noteworthy that statistical control for influential covariates is critical for detecting small differences between groups; however, caution is still required in interpreting the results from these models.
The CF REE values reported here are similar to those of Buchdahl et al. (8) , which were 7-9% above predicted using a regression equation generated from a comparable control group (Table 4) . Their patients with CF were children and adolescents with highly variable lung function. Vaisman et al. (7) found REE in patients with CF to be 18% above predicted using the HarrisBenedict equations (34); however, these equations are inappropriate for prediction in their younger subjects. Furthermore, Vaisman's patients with CF varied with respect to age and lung disease. Fried et al. ( 11)described a curvilinear relationship with increasing REE and decreasing pulmonary function in male patients with CF and variable lung disease. Our patients with CF represent a restricted range of mild to moderate lung disease where pulmonary function was not a major contributing factor to REE. The 6-9% increase in REE may be related to a number of factors, including an energyrequiring cellular defect; energy expenditure related to unmeasured, mild chronic pulmonary inflammation and infection; and an increase in work related to pulmonary disease not detected by these pulmonary function tests.
REE and genotype association was examined by Fried et al.
(II), who found no relationship, and by O'Rawe et al. (12) , who described an increased REE in the~F508 homozygous subgroup.
The latter results may be an artifact because of the use of the Harris-Benedict equations for nonadult subjects or because of the effect of severe lung disease and malnutrition in their CF group.
The TEE results reported here are similar to those of Shepherd et at. (9) , who found a 27% increase in TEE in clinically well infants and children with CF using the doubly labeled water method. Discussion of the interpretation of these data has centered mainly on the adequacy of the control group (35-38).
Spicher et al. (10) , using the 48-h heart rate monitor method for TEE, found no difference between CF and control groups despite higher REE for patients with CF. This lack of difference was attributed to reduced voluntary physical activity, i.e. compensation in the patients with CF. The exclusion of eight TEE values as a result of unacceptably high variability in reo 2 was probably due to contaminated samples or inaccurate analysis, not to disparate subject characteristics. One explanation for our 23% higher TEE in the AF508 homozygous subgroup is that voluntary physical activity was higher during the metabolic period. The four outlier patients may have exhibited extremes of activity, either typical or not, in their normal environment. Compensation by decreased physical activity as suggested by Spicher et al. (10) was not observed.
TEE/REE ratios, which are influenced mainly by physical activity, support this explanation, although the activity scores from parental observations do not. The AF508 homozygous subgroup ratio (1.85) was close to reference values for normal children (1.8 to 1.9) (39); however, the ratios of the other subgroups were lower. In comparison, the TEE/REE ratios reported by Spicher et al. (10) were 1.56 for CF and 1.73 for control subjects. Another explanation for higher TEE is that all three groups had similar levels of physical activity but that the energy cost of physical activity was greater in the homozygous subgroup. Grunow et al. (40) reported that energy expenditure was significantly increased during activities of daily living in normally nourished female patients with CF and that this incremental increase in energy from the resting state to each activity level was comparable in CF and control groups. Their study did not assess subjects by genotype. Future studies of TEE, combined with more direct measures of physical activity, are needed. Isotopic fractionation is an important issue in the clinical use of the doubly labeled water method and refers to the lower rate of vaporization of heavier isotopes compared with the lighter isotopes of the same element. It is assumed that breath water vapor and insensible transcutaneous water are fractionated and that sweat and urine are not (18) . We assumed that isotopic fractionation was the same for patients with CF and control subjects. CF results in abnormal amounts of sodium and chloride in the sweat without affecting the insensible water losses from the cutaneous layer. CO 2 concentration was assumed to be 3.5% of expired air for the fractionation calculations. To verify this, we measured CO 2 concentration in four patients with CF (mean ± SO, 2.5 ± 0.5%) and five control subjects (mean ± SO, 3.1 ± 0.8%) in this study. Assuming a CO 2 value of 2.5% resulted in a 1.8% lower re02 and 2.6% higher reo2 for maximal and minimal breath water loss, respectively. Because of these small reo2 differences, the original assumption of Schoeller et al. (18) Clinical significance. Children with CF who were selected because of their mild lung disease, good nutritional status, and normal growth had a modest (6-9%) increase in REE. This increase could not be explained by genotype or degree of lung disease. TEE from normal daily activity was also increased in children with CF, but the increase of 15% was greater than the 6-9% accounted for by REE alone. When TEE was examined by genotype, the AF508 homozygous subgroup demonstrated a 22% greater increase compared with that of the control children. Unexpectedly, children with non-AF508 homozygous mutations had equivalent TEE to controls. Because of the mixed heterogeneous nature of this subgroup, definite conclusions could not be drawn about its relationship to the AF508 homozygous subgroup or controls.
The increase in TEE in homozygous children may be related to increased voluntary physical activity as indicated by the TEE/ REE ratio, although the parental activity score did not support this. Other causes include the possibility that the AF508 homozygous mutation caused a cellular or adaptive response resulting in an increased energy requirement for a given amount of physical activity. The clinical implication of this pattern of energy expenditure is that REE, either measured or estimated from equations, may not reflect the variability of physical activity and therefore may poorly predict the total daily energy needs of children with CF. Detailed assessment of current physical activity level for each individual with CF may be necessary to determine an accurate caloric goal for optimal growth or nutritional rehabilitation .
This information may provide a basis for the interpretation of previous studies (Table 4) , explaining some of the conflicting findings expressed among studies because of varying subject populations. Recognition of the relationship between genotype and REE and TEE will aid our understanding of growth failure, malnutrition, and progression of pulmonary disease in children with CF.
